StonvexLoading…
StonvexCore line items from ABG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Annual 2024 2024-12-31 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 |
|---|---|---|---|---|---|
Revenue | $4.56B | $17.19B | $4.20B | $14.80B | $10.99B |
Operating Income | Not available | $835.60M | $262.80M | $953.50M | $829.00M |
Net Income | Not available | $430.30M | $147.10M | $602.50M | $547.00M |
EPS (Diluted) | $6.50 | $21.50 | $7.21 | $28.74 | $25.91 |
Total Assets | Not available | $10.34B | $10.13B | $10.16B | $8.26B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $69.40M | $29.00M | $45.70M | $41.60M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $170.70M | Not available |
Shares Outstanding | Not available | 20.00M | 20.40M | 21.00M | 21.10M |